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Abstract
Background: The removal of introns from pre-mRNA is carried out by a large macromolecular machine called the
spliceosome. The peptidyl-prolyl cis/trans isomerase PPIL1 is a component of the human spliceosome and binds to the
spliceosomal SKIP protein via a binding site distinct from its active site.
Principal Findings: Here, we have studied the PPIL1 protein and its interaction with SKIP biochemically and by X-ray
crystallography. A minimal linear binding epitope derived from the SKIP protein could be determined using a peptide array.
A 36-residue region of SKIP centred on an eight-residue epitope suffices to bind PPIL1 in pull-down experiments. The crystal
structure of PPIL1 in complex with the inhibitor cyclosporine A (CsA) was obtained at a resolution of 1.15 A ˚ and exhibited
two bound Cd
2+ ions that enabled SAD phasing. PPIL1 residues that have previously been implicated in binding of SKIP are
involved in the coordination of Cd
2+ ions in the present crystal structure. Employing the present crystal structure, the
determined minimal binding epitope and previously published NMR data [1], a molecular docking study was performed. In
the docked model of the PPIL1?SKIP interaction, a proline residue of SKIP is buried in a hydrophobic pocket of PPIL1. This
hydrophobic contact is encircled by several hydrogen bonds between the SKIP peptide and PPIL1.
Conclusion: We characterized a short, linear epitope of SKIP that is sufficient to bind the PPIL1 protein. Our data indicate
that this SKIP peptide could function in recruiting PPIL1 into the core of the spliceosome. We present a molecular model for
the binding mode of SKIP to PPIL1 which emphasizes the versatility of cyclophilin-type PPIases to engage in additional
interactions with other proteins apart from active site contacts despite their limited surface area.
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Introduction
Peptidyl-prolyl cis/trans isomerases (PPIases, E.C. 5.1.2.8) catalyze
the isomerization of peptide bonds that precede a proline residue
and can thereby facilitate folding of their substrate proteins [2].
PPIases are implicated in a number of cellular processes including
transcriptional control and pre-mRNA splicing [3]. These enzymes
have been documented in all three domains of life and have recently
also been found in a viral genome [4]. The PPIases belong to three
classes: cyclophilins (cyclosporine A binding proteins, Cyps), FK506-
binding proteins and parvulins. Proteomics analyses of spliceosomes
have revealed that eight cyclophilins are present in the human
spliceosome (reviewed by [5] and [6]). The abundance of these
enzymes in pre-mRNA splicing in humans is striking and raises the
question as to their contributions to the splicing cycle. The splicing
cycle comprises the ordered assembly of the spliceosome on its pre-
mRNA substrate, catalysis of the splicing reaction as well as the
disassembly and recycling of its components. Specifically, the
assembly is characterized by the stepwise recruitment of small
nuclear ribonucleoprotein particles (snRNPs) as well as non-snRNP
proteins. It is initiated by U1 snRNP binding to the 59-splice site
(complex E) followed by U2 snRNP recognizing a conserved branch
point sequence in the intron (complex A). Subsequently, a pre-
formed U4/U6-U5 tri-snRNP is integrated, giving rise to the pre-
catalytic complex B spliceosome, which is still inactive. This particle
undergoes compositional and conformational rearrangements to
becomecatalyticallycompetentforthefirststep,resultingincomplex
B*. Complex B* carries out the first transesterification reaction.
Afterwards, remodeling generates a spliceosome that catalyzes the
second step (complex C). Finally, the post-catalytic complex is
disassembled in an ordered fashion.
Peptidyl-prolyl isomerase like 1 (PPIL1) is a cyclophilin and
belongs to the so-called Prp19-related proteins [5]. It is recruited
into the spliceosome at the stage of complex B formation. It was
recently defined as a core component of complex C, since it
remains in the complex even after treatment with 1 M NaCl [7].
PPIL1 is a single domain cyclophilin and has been found to
interact with the Ski-interacting protein (SKIP, also referred to as
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coactivator NCoA-62). SKIP itself is a Prp19-related protein [5]
that is stably integrated into the C complex [7] and whose ortholog
in Saccharomyces cerevisiae, Prp45, is essential for pre-mRNA splicing
[8]. In addition to its presence in splicing complexes, SKIP has
also been found to act as a co-activator of Notch-, VDR- and
SMAD-regulated transcription (see [9] for review) and was
therefore thought to be a factor that links transcription and
splicing. However, more recent data suggest that the roles of SKIP
in transcription and splicing are independent [10].
PPIL1 is up-regulated in human colon cancer cells and an
siRNA-mediated knockdown of PPIL1 resulted in a reduced
number of viable cells [11]. Analogous to the binding mode of the
spliceosomal hPrp4 protein to cyclophilin H [12], the PPIL1?SKIP
interaction does not occupy the PPIase active site [1,13], which
suggests that SKIP serves as an adaptor for the cyclophilin. This
finding has led to the speculation that SKIP and PPIL1 could
participate in the activation of the spliceosome by SKIP delivering
the cyclophilin to a site where remodeling is required [9].
However, in contrast to SKIP, human PPIL1 does not have an
ortholog in S. cerevisiae.
Here, we investigated the PPIL1 protein biochemically and
structurally. We could delineate a minimal PPIL1-binding epitope
of the SKIP protein sufficient to pull-down PPIL1 protein. An
atomic resolution crystal structure of PPIL1 in complex with the
inhibitor CsA, the identification of the minimal PPIL1-binding
epitope of SKIP and previously published NMR data [1] enabled
us to carry out a molecular docking study. The docked model of
the PPIL1?SKIP interaction suggests a novel protein-binding
surface of a cyclophilin.
Results
Identification of a PPIL1-binding SKIP epitope by a
peptide array
Based on its amino acid sequence, several algorithms predict that
the SKIP protein is intrinsically unstructured to a large extent (not
shown). We therefore speculated that it may interact with PPIL1 via
a linear binding epitope. Xu et al. [1] could narrow down SKIP
residues that interact with PPIL1 to a region comprising amino
acids 59 to 129 by a GST pull-down experiment. In order to map
the PPIL1-interacting region of SKIP at single amino acid
resolution, a peptide array analysis was performed. A total of 73
20-merpeptidescovering SKIP residues49 to 140 witha oneamino
acid offset were synthesized in duplicate as a spot array on cellulose
membranes (kind gift of Dr. C. Freund, FMP, Berlin, Germany).
Recombinant GST-PPIL1 bound strongly to a stretch of con-
secutive peptides in the array (Figure 1A, upper panel), indicating a
linear PPIL1-binding epitope on SKIP. A control experiment with
GST alone did not show significant signal above the background
(Figure 1A, lower panel). The minimal binding sequence, present in
all interacting peptides, is
61GGAFPEIH
68 (Figure 1B).
GST pull-down experiments confirm the mapped SKIP
epitope
To confirm the binding epitope as mapped by the peptide array
experiment, a GST-fusion construct containing SKIP residues 43–79
was employed for GST pull-down experiments using purified PPIL1
protein. This construct encompasses a longer SKIP-polypeptide than
the minimal epitope derived from the peptide array in order to allow
formation of short secondary structure elements neighboring the
immediate interaction region, as previously seen in the CypH-
binding loop of hPrp4 [12]. Figure 2 shows that the mapped epitope
comprising SKIP residues 43 to 79 fused to GST is sufficient to pull-
down purified PPIL1, while GST alone does not pull-down PPIL1,
indicating a specific binding reaction. The interaction persists under
stringent washing conditions (1 M NaCl and 0.1% (w/v) Triton
X-100). However, the complex was unstable during size exclusion
chromatography (not shown), suggesting kinetic instability of the
complex.
Crystal structure of PPIL1 bound to cyclosporine A
PPIL1 protein was subjected to crystallization trials in the
presence of synthetic peptides encompassing SKIP residues 55–74
and 44–74 (synthesized by Peptide Specialty Laboratories,
Heidelberg, Germany). To sample a larger crystallization
parameter space, the active site inhibitor CsA was included in a
set of samples. Crystals were obtained in samples containing both
SKIP 44–74 peptide and CsA and grew as clusters of rectangular
plates. Singularized crystals diffracted to a resolution of 1.15 A ˚
and exhibited two bound Cd
2+ ions that enabled SAD phasing
(Table 1). The experimental electron density was of excellent
quality (Figure 3B) and permitted automated model building with
Arp/wArp for 90% of the model. The final model comprises full-
length PPIL1 protein (except the very N-terminal Met) bound to
CsA without any geometry violations and with good R-factors
(Table 1). However, neither the experimental electron density map
nor the map obtained after refinement showed electron density for
a bound SKIP peptide. The lack of electron density for the SKIP-
peptide indicates that the peptide, although present in twofold
molar excess in the crystallization setup, was excluded from the
crystal during nucleation and growth. At a later stage, using
refined crystallization conditions, morphologically similar crystals
could be produced with PPIL1?CsA complex lacking the SKIP
peptide, suggesting that the SKIP peptide was not necessary for
crystallization.
PPIL1 exhibits the canonical cyclophilin fold comprising an
eight-stranded antiparallel b-sheet capped on both sides by a-
helices (Figure 3A). The secondary structure of the present PPIL1
is identical to that of the archetypical cyclophilin, CypA [14,15].
As known from other cyclophilins, the active site is located on
strands b3 and b4. All CsA-contacting residues of PPIL1 are
conserved and exhibit the same side chain rotamers as observed
for CypA in complex with CsA, rendering the active site geometry
essentially identical to CypA and other CypA-type cyclophilins.
Cadmium ions mediate crystal contacts
The structure of the PPIL1?CsA complex contains two Cd
2+
ions in an asymmetric unit. Both ions are coordinated by the
PPIL1 protein and water molecules such that contacts between
two neighboring PPIL1 molecules in the crystal lattice are
established (Figure 4A). Cd1 is complexed in a distorted penta-
coordinate manner by His31, Asp89, a solvent molecule and the
symmetry-related Cys133. The carboxylate group of Asp89 acts
as a symmetrical bidentate ligand for Cd1, which can alternatively
be viewed as a single ligand centered at the position of its carbon
[16]. This binding mode yields a slightly distorted tetrahedral
coordination geometry with a mean angle of 109.0u (standard
deviation 9.3u, Table S1). In constrast, Cd2 is coordinated by the
carboxylate group of Glu26 in a monodentate fashion. The other
ligands of Cd2 are Cys133, a solvent molecule and the symmetry-
related His87, resulting in a distorted tetrahedral geometry (mean
angle 108.6u, standard deviation 14.2u, Table S1). The bridging
Cys133 coordinates both Cd
2+ ions at almost equivalent distances
(2.54 A ˚ and 2.49 A ˚ respectively), resulting in a Cd1–Cys133Sc–
Cd2 angle of 111.2u. These intricate interactions readily explain
why PPIL1?CsA crystals could only be grown in the presence of
CdCl2. Like zinc, cadmium possesses a filled d
10 orbital shell and is
The PPIL1?SKIP Interaction
PLoS ONE | www.plosone.org 2 April 2010 | Volume 5 | Issue 4 | e10013therefore able to accommodate different coordination geometries
of similar energy. The tendency of cadmium as a soft transition
metal to bind to thiolate groups is likely the reason why cadmium
could not be substituted by other divalent transition metals.
Using HSQC-NMR experiments, Xu et al. [1] were able to
pinpoint a number of PPIL1 surface-exposed residues that undergo
chemical shift perturbations upon titration with SKIP59–129.
Strikingly, these residues (highlighted in Figure 4B) involve the
residues His87, Asp89 and Cys133, which coordinate Cd
2+ ions in
the present crystal structure. In addition, all other presumed SKIP-
binding residues [1] are in close vicinity of the Cd
2+ binding site.
This finding suggests that Cd
2+-mediated crystal packing presum-
ably excluded the SKIP peptide during crystallization.
Molecular docking suggests a model for the PPIL1?SKIP
interaction
Lacking crystallographic data of the SKIP peptide interacting
with PPIL1, an in silico molecular docking study was performed
using the High Ambiguity Driven protein-protein Docking
algorithm (HADDOCK, [17]). The coordinates for the PPIL1
protein were taken from the current crystal structure without
modifications, while coordinates for a ten-residue SKIP peptide
were modeled ab initio (see Materials and Methods). Restraints for
docking were based on experimental data of the PPIL1-binding
epitope of SKIP as mapped by peptide array analysis and SKIP-
interacting residues as mapped by HSQC-NMR by [1].
Solutions were clustered automatically and resulted in a single
cluster of docking results, which stood out among the remaining
clusters: The score was 240.568.6 for the best-scoring cluster,
whereas next best clusters had scores of 227.4610.1, 226.864.1
and 226.564.8 respectively. Likewise, all cluster evaluation
parameters showed a significantly better performance of the
best-scoring cluster versus the remaining clusters. For example,
structures from the best-scoring cluster showed the smallest
r.m.s.d. from the overall lowest-energy structure (0.5 A ˚60.3 A ˚)
and the largest buried surface areas (728.3 A ˚ 26106.4 A ˚ 2),
suggesting that solutions of the best-scoring cluster present sensible
models for the interaction.
Figure 1. PPIL1 binds short epitopes of SKIP in peptide scanning experiments. (A) Peptide scan analysis of the PPIL1?SKIP interaction.
Cellulose-bound peptide arrays were successively incubated with GST-PPIL1 fusion protein (upper panel) or GST alone (lower panel), rabbit a-GST
antibody and horseradish peroxidase-coupled goat a-rabbit antibody. Images were obtained after luminol reaction. The locations of the spotted
peptides are indicated by red circles. (B) Binding peptides exhibiting luminol signal above background. The consensus sequence common to all
binding peptides is highlighted.
doi:10.1371/journal.pone.0010013.g001
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cluster of the HADDOCK docking run. In this model, the SKIP
peptide adopts a loop structure sliding Pro65 into a hydrophobic
groove formed by Ile97 and the aliphatic region of the side chain
of Arg131 of PPIL1. The acidic Glu66 side chain of the SKIP
peptide engages in hydrogen bonds/ion bridges to three PPIL1
residues, i.e. Tyr28, Lys30 and Arg131. Furthermore His68 of
SKIP is bound by Asp89 and Thr93 of PPIL1. Overall, the SKIP
peptide adopts a conformation that allows a snug fit into a pocket
of PPIL1, which is essentially unchanged compared to the Cd
2+-
ion dependent crystal structure of PPIL1 (r.m.s.d. for docked
PPIL1 to crystal structure is 0.45 A ˚).
Discussion
PPIL1 binds to a short, linear SKIP epitope
PPIL1 is a spliceosomal cyclophilin that possesses two striking
features among the eight known human spliceosomal cyclophilins.
First, PPIL1 is one of two cyclophilins that is tightly integrated into
the human spliceosomal C complex (as is CypE) as evidenced by
high-salt treatment and gradient centrifugation [7]. Second, PPIL1
can interact with the SKIP protein without involving its PPIase active
site [1,13]. A peptide scan revealed that a minimal binding epitope
consisting of SKIP amino acids 61 to 68 is sufficient for PPIL1
binding. This epitope is also contained in a GST-SKIP
43–79 construct
that can efficiently pull-down PPIL1. The GST-SKIP
43–79?PPIL1
interaction is stable in high-salt conditions, which argues for SKIP
functioning as an adaptor protein that integrates PPIL1 into the high-
salt-resistant core of the human spliceosome. SKIP is predicted to be
intrinsically unstructured; therefore it could undergo a disorder-to-
order transition upon integration into the spliceosome and thereby
deliver PPIL1 to a specific site where PPIase activity is required. In
vitro, the PPIL1?SKIP interaction is kinetically unstable and the
complex disintegrates during size exclusion chromatography.
Docking of a SKIP peptide to the PPIL1?CsA crystal
structure suggests that binding occurs via a novel
binding interface
The present crystal structure showed full-length PPIL1 protein
in complex with CsA but did not reveal electron density for the
SKIP peptide that was added in two-fold molar excess. Instead,
PPIL1 residues that have been mapped by HSQC-NMR to
interact with SKIP [1] are coordinating Cd
2+ ions. Cd
2+ ions are
directly involved in crystal packing and it appears, thus, that Cd
2+-
mediated crystal packing has excluded the SKIP peptide from the
crystals. The Cd
2+ ions are coordinated at a distinct site of the
protein that comprises residues in the EF-loop of the cyclophilin
(Asp89, Lys91) as well as Tyr28 of the BC-loop and Arg131 of the
bI sheet. It is noteworthy that these residues are not conserved
among cyclophilins (e.g. Asp89 appears to be unique among
spliceosomal cyclophilins; Figure S1). Furthermore, these residues
are spatially distinct from the hPrp4-binding site of CypH, which is
primarily located on its extended CD-loop that forms a b-hairpin
[12].
The PPIL1?CsA crystal structure exhibits a generally more
compact shape compared to a previously published NMR
structure ensemble of PPIL1[1]. In particular, the N-terminus of
the protein is not disordered as reported for the NMR structure. It
folds over the a1 helix by Ile4 engaging in van der Waals contacts
with Tyr78 and Leu86.
Model for the PPIL1?SKIP interaction
The present molecular docking study provides a model for the
PPIL1?SKIP interaction, in which the SKIP peptide binds into a
pre-formed pocket of PPIL1 that has not been observed in other
cyclophilins before. The buried surface area of the complex is
728 A ˚6106 A ˚, which is comparable to the area buried in the case
of the CypH?hPrp4 complex (878 A ˚).
Figure 2. SKIP43–79 is sufficient to pull-down PPIL1. Pull-down of purified PPIL1 with glutathione-sepharose beads pre-coated with
recombinant GST-SKIP
43–79 (lanes 2 and 3) shows that PPIL1 binds to the mapped SKIP epitope, while GST alone (lanes 4 and 5) does not bind PPIL1.
NaCl concentration in the washing buffer was varied between 150 mM (lanes 1, 2 and 4) and 1 M (lanes 3 and 5). Input (lane 1) and bound fractions
(lanes 2 to 5) were analyzed by SDS-PAGE and stained with Coomassie. The band below the GST-SKIP fusion protein in lanes 2 and 3 is likely an
abortive translation product corresponding to GST alone.
doi:10.1371/journal.pone.0010013.g002
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herein involves a proline residue of SKIP buried in a hydrophobic
pocket of the PPIL1 protein. The active site of cyclophilins also
exhibits affinity for Pro-containing peptides, raising the question of
why the SKIP-peptide selectively binds to the alternative pocket.
Our model suggests that Glu66 of SKIP, neighboring the central
Pro65, could act as a discriminator. The Glu66 carboxyl group of
SKIP engages in polar contacts to the PPIL1 protein, showing that
it is a critical anchoring point of the SKIP peptide.
During the finalization of this work, a study describing an
NMR-ensemble of the PPIL1?SKIP interaction was published
[18]. The NMR data were recorded from a fusion protein that
contains a SKIP polypeptide connected to the PPIL1 protein by a
flexible linker. Strikingly, this ensemble shows high similarity with
the present docked model. For instance, the directionality of the
SKIP peptide, the geometry of the binding pocket of PPIL1 and
the function of Glu66 of SKIP as an anchoring point are very
similar. However, [18] discerned an additional important site of
interaction in the methyl group of Met76 of SKIP that was not
found in the present study. The minimal PPIL1-binding peptide
extracted from our array analysis does not include Met76,
although a strong signal is observed on peptide A12 (Figure 1A),
which includes Met76 at position 17. It is possible that a peptide
array harboring peptides longer than 20 residues could have
detected this additional anchoring point. Moreover, [18] describes
an NOE distance constraint between Asp60 (numbered Asp184 in
[18] due to the fusion construct) and Ile136 of PPIL1. This
interaction was not found in our docked model, because Ile136 has
not been described previously as a SKIP-interacting residue and
was therefore not defined as an ‘‘active residue’’ in our docking
run. In conclusion, our docking procedure succeeded in describing
a large part of the PPIL1?SKIP interaction identifying a novel
protein-protein interaction surface on a cyclophilin.
Materials and Methods
Cloning, protein expression and purification
A DNA fragment encoding full-length human PPIL1 protein was
PCR-amplified from a human cDNA library (Marathon-Ready;
Clontech, Mountain View, CA, USA) and cloned via BamHI/NotI
restriction sites into the expression vector pGEX-6P1 (GE Healthcare,
Freiburg, Germany). A synthetic DNA fragment encoding SKIP
43–79,
att sites, a TEV cleavage site and a stop codon were generated using
the AssemblyPCRoligomaker [19] and a PCR protocol as suggested
by the authors. The PCR product was inserted into the pET-G30
Table 1. Crystallographic data and refinement.
Data Collection
Set1
(phasing)
Set2
(high resolution)
Wavelength (A ˚)1 . 5 0 . 9
Temperature (K) 100 100
Space Group P21212 P21212
Unit Cell Parameters (A ˚) 103.2 35.7 45.9 103.2 35.7 45.9
Resolution (A ˚)5 0 . 0 21.79
(1.8921.79)
a
50.021.15
(1.2521.15)
Reflections
Unique 16,563 62,933
Completeness (%) 99.9 (99.5) 99.8 (99.4)
Redundancy 14.6 (14.5) 6.7 (6.1)
Mean I/s(I) 19.2 (5.6) 8.9 (2.0)
Rsym(I)
b 11.9 (45.8) 8.6 (44.4)
Phasing
Resolution (A ˚)2 . 5
Heavy Atom Sites 2
Correlation Coefficients
c
SHELXD CC/CCweak 39.0/24.9
Pseudo-Free CC Left/Right
Hand
82.0/55.1
Refinement
Resolution (A ˚)3 5 . 0 21.15
Reflections
Number 61,160
Completeness (%) 99.9
Test Set (%) 5
Rwork
d (%) 12.8
Rfree
d (%) 14.9
ESU (A ˚)
e 0.09
Contents of A.U.
f
Protein Molecules/
Residues/Atoms
1/167/3138
Water Oxygens 294
Ligand Molecules/Atoms 1/191
Mean B-Factors (A ˚2)
Wilson 8.13
Protein 12.3
Water 27.8
Ligand 14.3
Ramachandran Plot
g
Preferred 162
Allowed 6
Disallowed -
r.m.s.d.
h from Target
Geometry
Bond Lengths (A ˚)0 . 0 0 9
Bond Angles (u) 2.20
Chirality (A ˚)0 . 0 7 4
Dihedral Angles (u)1 7 . 9 9 7
Refinement
PDB ID 2X7K
aData for the highest resolution shell in parentheses.
bRsym(I)=ShklSi|Ii(hkl)2,I(hkl).|/ShklSi|Ii(hkl)|; for n independent reflections
and i observations of a given reflection; ,I(hkl). – average intensity of the
i observations.
cCC=[SwEoEcSw2SwEoSwEc]/{[SwEo
2Sw2(SwEo)
2][ SwEc
2Sw2(SwEc)
2]}
K;
w – weight (see http://shelx.uni-ac.gwdg.de/SHELX/shelx_de.pdf for full
definitions).
dR=Shkl||Fobs|2|Fcalc||/Shkl|Fobs|; Rwork2hkl 1 T; Rfree2hkl M T; Rall – all
reflections; T – test set.
eESU – estimated overall coordinate error based on maximum likelihood.
fA.U. – asymmetric unit.
gAccording to [26].
hRmsd – root-mean-square deviation.
doi:10.1371/journal.pone.0010013.t001
Table 1. Cont.
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protocol following the manufacturer’s instructions (Invitrogen,
Carlsbad, US). For protein expression, plasmids were transformed
into Rosetta 2 cells (Novagen, Madison, WI, US). Expression was
performed at 16uC using an auto-inducing medium [20].
Bacterial cells were lyzed by using a microfluidizer (Micro-
fluidics, Newton, MA, US). Clarified lysate was passed over
glutathione-sepharose (GE Healthcare) according to the manu-
facturer’s instructions. After cleavage of the affinity tag with
PreScission protease, the sample was dialyzed against buffer A
Figure 4. Cadmium ions are coordinated by two neighboring PPIL1 molecules and solvent molecules. (A) Cd1 (gold sphere) is
coordinated by Asp89 in a bidentate fashion and by His31 of one PPIL1 molecule (carbon atoms in light blue) as well as by Cys133 of the (1/2-x, y-1/2,
-z)-symmetry-related molecule (carbon atoms in green). The fourth coordination is site taken by a solvent molecule (red sphere). Cd2 shown here is
(1/2-x, y-1/2, -z)-symmetry-related and coordinated by His87 of the present molecule and Glu26 and Cys133 of the (1/2-x, y-1/2, -z)-symmetry-related
molecule as well as a solvent molecule. (B) Carbon atoms of PPIL1 residues that have been previously mapped to interact with a SKIP peptide by
HSQC-NMR [1] are shown in magenta. These residues include the Cd
2+-coordinating residues His87, Asp89 and Cys133.
doi:10.1371/journal.pone.0010013.g004
Figure 3. Crystal structure of the PPIL1?CsA complex. (A) Cartoon representation of PPIL1 with bound CsA (carbon atoms: brown) and two
Cd
2+ ions (golden spheres). (B) Experimental electron density obtained by SAD phasing contoured at the 2s level (grey mesh). The final model is
displayed as sticks.
doi:10.1371/journal.pone.0010013.g003
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passed again over the affinity resin to remove remaining
uncleaved species. Protein was collected in the flow-through
and subjected to a final size exclusion chromatography (Superdex
75) in buffer A. Pooled fractions were concentrated to 20 mg/ml
by ultrafiltration, aliquoted and flash-frozen in liquid nitrogen for
storage at 270uC. For co-crystallization, complex formation with
CsA (Sigma-Aldrich, Schnelldorf, Germany) was carried out in
the absence of organic solvents by diluting the protein into a large
volume of buffer A and addition of solid CsA in 5-fold molar
excess as described [21]. The suspension was rotated gently
overnight at 4uC, followed by removal of excess insoluble CsA by
centrifugation. Supernatant protein?CsA complex was concen-
trated to 20 mg/ml (PPIL1) and used immediately for crystalli-
zation trials.
Peptide array binding experiments
A total of 73 overlapping 20-mer peptides covering amino
acids 49 to 140 of SKIP with a one amino acid offset were
synthesized and assembled in duplicate as an array of spots on
cellulose membranes (kind gift of Dr. C. Freund, FMP, Berlin,
Germany). Membranes were washed for 10 min in 100%
ethanol followed by three times washing for 10 min with 16
T B Sb u f f e r( 1 3 0m MN a C l ,2 . 8m MK C l ,5 0m MT r i s - H C l ,
pH 8.0) to remove residual contaminants. Membranes were pre-
blocked for 3 h in blocking buffer (5% (w/v) milk powder, 5%
(w/v) saccharose in 16 TBS) and washed again for 10 min in
16TBS. GST-PPIL1 fusion protein or GST alone were diluted
in blocking buffer to a final concentration of 40 mg/ml.
Membranes were incubated overnight at 4uC on a rocking
platform. Unbound protein was removed by washing the
membranes three times with 16 TBS. Subsequently, the
membranes were incubated for 3 h at RT with anti-GST-
antibody (GST (Z-5) sc-459, Santa Cruz Biotechnology, USA)
diluted 1:1000 in blocking buffer, washed three times with 16
TBS and incubated for 1.5 h with secondary antibody
(peroxidase-conjugated a-rabbit, Jackson Immunoresearch,
USA, diluted 1:25000). The membranes were washed five times
with 16 TBS and subsequently treated with ECL reagent
(Perkin Elmer, MA, USA). Chemiluminescence was detected
with a luminescent image analyzer (LAS-1000 Fujifilm)
equipped with an appropriate set of filters.
GST pull-down assay
GST and the GST-fusion polypeptide were captured on
glutathione-coated sepharose beads (GE Healthcare) and washed
extensively with TET-150 buffer (20 mM Tris-HCl, pH 7.5,
150 mM NaCl, 3 mM EDTA, 1 mM b-mercaptoethanol, 0.1%
(v/v) Triton X-100). For each reaction, 50 mg of purified PPIL1
were incubated with 20 ml of protein-coated glutathione-beads for
2 h at 4uC on an overhead shaker. After extensive washing with
either TET-150 or TET-1000 buffer (as TET-150, but 1 M
NaCl), proteins were eluted by addition of SDS sample buffer and
analyzed by SDS-PAGE.
Figure 5. A docked model for the PPIL1?SKIP interaction. The SKIP peptide (carbon atoms gold) adopts a loop structure, in which the central
Pro65 is buried in a hydrophobic groove formed by Ile97 and the aliphatic region of the side chain of Arg131 of PPIL1 (PPIL1 carbon atoms light blue).
The Glu66 side chain of the SKIP peptide engages in hydrogen bonds to PPIL1 residues Tyr28, Lys30 and Arg131. Furthermore, His68 of SKIP is bound
by Asp89 and Thr93 of PPIL1.
doi:10.1371/journal.pone.0010013.g005
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PPIL1 or PPIL1?CsA were mixed with synthetic SKIP peptides
encompassing SKIP residues 55–74 and 44–74 (synthesized by
Peptide Specialty Laboratories, Heidelberg, Germany) in twofold
molar excess yielding a total final protein concentration of 12 mg/
ml. Initial hits were found in trials of sample containing PPIL1,
CsA and SKIP
44–74. Despite extensive efforts, no conditions could
be found that promoted the growth of single crystals. Thus,
crystals from a plate cluster grown at 4uC in 0.1 M HEPES,
pH 7.2, 0.7 M sodium acetate, 15 mM CdCl2 and 50 mM
guanidine-HCl were singularized using an acupuncture needle.
For data collection at cryogenic temperatures, the crystal was
transferred into paratone N and flash-cooled in liquid nitrogen.
Two datasets from the same crystal were collected at BESSY
beamline 14.2 at different wavelengths. At a wavelength of 1.5 A ˚,
data were collected to a resolution of 1.8 A ˚ recording anomalous
signal for Cd
2+. After collecting a full Q-scan, the wavelength was
tuned to the maximum photon flux (0.9 A ˚), which yielded a
dataset to a maximum resolution of 1.15 A ˚. Diffraction data were
processed with XDS [22].
Structure solution and refinement
For SAD phasing of PPIL1?CsA, Shelx [23] was employed.
Using diffraction data up to 1.8 A ˚ resolution collected at a
wavelength of 1.5 A ˚ (for which I/s(I).2), ShelxD clearly
located two Cd
2+ ions per asymmetric unit with correlation
coefficients of 39.0%/24.9% (CCall/CCweak). For density
modification with ShelxE, the high-resolution data set was
merged with the data set used for phasing. The pseudo-free
correlation coefficient for the correct hand was clearly better
than for the other hand (82% vs. 55%), indicating that a correct
solution had been found. Automated model building with ARP/
wARP resulted in a model comprising more than 90% of the
expected protein residues. The FOM-weighted mean phase
error relative to the final refined model was 23.4u. Refinement
was conducted using the PHENIX package [24]. 5% of the data
were set aside as a test set for calc u l a t i o no ft h ef r e eR - f a c t o r .
Ordered solvent was included as implemented in PHENIX.
Coordinates of the refined structures and the structure factor
amplitudes have been deposited in the Protein Data Bank
(http://www.pdb.org, PDB ID 2x7k).
Molecular docking
The coordinates for the PPIL1 protein were taken from the
current crystal structure without modifications. Coordinates for a
ten-residue SKIP peptide (sequence DGGAFPEIHV comprising
SKIP residues 60 to 69) were generated by Pepfold [25] and
geometry-minimized using the PHENIX package [24]. Restraints
for the docking run were generated based on experimental data of
the PPIL1-binding epitope of SKIP as mapped by peptide array
analysis and SKIP-interacting residues of PPIL1 as mapped by
HSQC-NMR by [1]. The charged SKIP residues Glu66 and
His68 as well as the polar PPIL1 residues Tyr28, Asp89 and
Arg131 were defined as ‘‘active residues’’. Such ‘‘active residues’’
are residues required to have an interface contact of ambiguous
distance. Passive residues were defined automatically as residues
around active residues. Docking was carried out with default
settings as semi-flexible simulated annealing followed by a final
refinement in explicit water.
Supporting Information
Figure S1 Multiple sequence alignment of human spliceosomal
cyclophilins. The non-conserved Asp89 residue of PPIL1 is
indicated by a grey arrow. The alignment was generated with
T-Coffee (Notredame C, Higgins DG, Heringa J (2000) T-Coffee:
A novel method for fast and accurate multiple sequence
alignment. J Mol Biol 302: 205–217). Sequence numbering
concerns the PPIase domains only, therefore it is distinct from
the total residue numbers in the cases of PPIL2, PPWD1 and
CypE (these proteins harbor domains preceding the PPIase
domain).
Found at: doi:10.1371/journal.pone.0010013.s001 (0.84 MB TIF)
Table S1 Selected bond lengths and angles of the Cd
2+
coordination groups.
Found at: doi:10.1371/journal.pone.0010013.s002 (0.04 MB
DOC)
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